Works matching DE "LYMPHOMA treatment"

Results: 2260
    1

    Current concepts of radioimmonotherapy for lymphoma.

    Published in:
    Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2015, v. 72, n. 7, p. 625, doi. 10.2298/VSP141125070M
    By:
    • Mihailović, Jasna;
    • Ubavićt, Milan;
    • Trifunović, Jasna
    Publication type:
    Article
    2
    3

    Double-hit primary unilateral adrenal lymphoma with good outcome.

    Published in:
    Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2014, v. 71, n. 7, p. 689, doi. 10.2298/VSP1407689M
    By:
    • Marković, Olivera;
    • Marisavljević, Dragomir;
    • Jelić, Svetlana;
    • Mihaljević, Biljana;
    • Martinović, Tamara;
    • Čemerikić, Vesna
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Post-treatment T1 shortening in primary CNS lymphoma.

    Published in:
    Journal of Neuro-Oncology, 2013, v. 111, n. 1, p. 25, doi. 10.1007/s11060-012-0984-3
    By:
    • Karimi, Sasan;
    • Hatzoglou, Vaios;
    • Punia, Vineet;
    • Partovi, Sasan;
    • Abrey, Lauren;
    • Deangelis, Lisa
    Publication type:
    Article
    16
    17
    18

    Prophylactic intrathecal chemotherapy in primary CNS lymphoma.

    Published in:
    Journal of Neuro-Oncology, 2012, v. 106, n. 1, p. 143, doi. 10.1007/s11060-011-0649-7
    By:
    • Sierra del Rio, Monica;
    • Ricard, Damien;
    • Houillier, Caroline;
    • Navarro, Soledad;
    • Gonzalez-Aguilar, Alberto;
    • Idbaih, Ahmed;
    • Kaloshi, Gentian;
    • Elhallani, Soufiane;
    • Omuro, Antonio;
    • Choquet, Sylvain;
    • Soussain, Carole;
    • Hoang-Xuan, Khé
    Publication type:
    Article
    19
    20
    21
    22
    23
    24

    Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study).

    Published in:
    Pathology & Oncology Research, 2018, v. 24, n. 2, p. 199, doi. 10.1007/s12253-017-0234-2
    By:
    • Schneider, Tamás;
    • Rosta, András;
    • Losonczy, Hajna;
    • Radványi, Gáspár;
    • Ujj, György;
    • Egyed, Miklós;
    • Illés, Árpád;
    • Jakucs, János;
    • Szerafin, László;
    • Gasztonyi, Zoltán;
    • Masszi, Tamás;
    • Iványi, János;
    • Demeter, Judit;
    • Dombi, Péter;
    • Tóth, Antal;
    • Borbényi, Zita
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 7, p. 1, doi. 10.1093/jnci/djv106
    By:
    • Cheung, Matthew C.;
    • Hay, Annette E.;
    • Crump, Michael;
    • Imrie, Kevin R.;
    • Song, Yuyao;
    • Hassan, Shazia;
    • Risebrough, Nancy;
    • Sussman, Jonathan;
    • Couban, Stephen;
    • MacDonald, David;
    • Kukreti, Vishal;
    • Kouroukis, C. Tom;
    • Baetz, Tara;
    • Szwajcer, David;
    • Desjardins, Pierre;
    • Shepherd, Lois;
    • Meyer, Ralph M.;
    • Le, Al;
    • Chen, Bingshu E.;
    • Mittmann, Nicole
    Publication type:
    Article
    43
    44

    Risk of Premature Menopause After Treatment for Hodgkin’s Lymphoma.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 9, p. 1, doi. 10.1093/jnci/dju207
    By:
    • Swerdlow, Anthony J.;
    • Cooke, Rosie;
    • Bates, Andrew;
    • Cunningham, David;
    • Falk, Stephen J.;
    • Gilson, Dianne;
    • Hancock, Barry W.;
    • Harris, Sarah J.;
    • Horwich, Alan;
    • Hoskin, Peter J.;
    • Linch, David C.;
    • Lister, Andrew;
    • Lucraft, Helen H.;
    • Radford, John;
    • Stevens, Andrea M.;
    • Syndikus, Isabel;
    • Williams, Michael V.
    Publication type:
    Article
    45
    46
    47
    48

    Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID‐19 pandemic.

    Published in:
    Internal Medicine Journal, 2020, v. 50, n. 6, p. 667, doi. 10.1111/imj.14859
    By:
    • Di Ciaccio, Pietro;
    • McCaughan, Georgia;
    • Trotman, Judith;
    • Ho, Phoebe Joy;
    • Cheah, Chan Y.;
    • Gangatharan, Shane;
    • Wight, Joel;
    • Ku, Matthew;
    • Quach, Hang;
    • Gasiorowski, Robin;
    • Polizzotto, Mark N.;
    • Prince, Henry Miles;
    • Mulligan, Stephen;
    • Tam, Constantine S.;
    • Gregory, Gareth;
    • Hapgood, Greg;
    • Spencer, Andrew;
    • Dickinson, Michael;
    • Latimer, Maya;
    • Johnston, Anna
    Publication type:
    Article
    49
    50